Clinical Benefits with Oseltamivir in Treating Influenza in Adult PopulationsResults of a Pooled and Subgroup Analysis

被引：0
|
作者：
S. Singh
J. Barghoorn
A. Bagdonas
J. Adler
J. Treanor
N. Kinnersley
P. Ward
机构：
[1] SARC Research Center,Infectious Diseases Unit
[2] Red Cross Hospital,undefined
[3] University of Rochester,undefined
[4] Roche Global Development,undefined
来源：
Clinical Drug Investigation | 2003年 / 23卷
关键词：
Influenza; Oseltamivir; Influenza Infection; ITTI Population; Accelerate Failure Time Model;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：561 / 569
页数：8
相关论文
共 50 条
  • [41] A pooled subgroup analysis of glucarpidase treatment in 86 pediatric, adolescent, and young adult patients receiving high-dose methotrexate therapy in open-label trials
    Janeway, Katherine A.
    Gros, Luis
    Schwartz, Stefan
    Daugherty, Claire
    Gallardo, Eva
    Hill, Christon
    Thomas, Emma
    Ward, Suzanne
    Rizzari, Carmelo
    PEDIATRIC BLOOD & CANCER, 2023, 70 (09)
  • [42] Detection of influenza and non-influenza respiratory viruses in lower respiratory tract specimens among hospitalized adult patients and analysis of the clinical outcome
    Hsu, Ching-Hao
    Chen, Hsin-Pai
    Chen, Po-Liang
    Chan, Yu-Jiun
    JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2022, 55 (05) : 820 - 828
  • [43] Effect of tocilizumab on neutrophils in adult patients with rheumatoid arthritis: pooled analysis of data from phase 3 and 4 clinical trials
    Moots, Robert J.
    Sebba, Anthony
    Rigby, William
    Ostor, Andrew
    Porter-Brown, Benjamin
    Donaldson, Francis
    Dimonaco, Sophie
    Rubbert-Roth, Andrea
    van Vollenhoven, Ronald
    Genovese, Mark C.
    RHEUMATOLOGY, 2017, 56 (04) : 541 - 549
  • [44] Prognostic value of Ki-67 index in adult medulloblastoma after accounting for molecular subgroup: a retrospective clinical and molecular analysis
    Fu Zhao
    Jing Zhang
    Peng Li
    Qiangyi Zhou
    Shun Zhang
    Chi Zhao
    Bo Wang
    Zhijun Yang
    Chunde Li
    Pinan Liu
    Journal of Neuro-Oncology, 2018, 139 : 333 - 340
  • [45] Prognostic value of Ki-67 index in adult medulloblastoma after accounting for molecular subgroup: a retrospective clinical and molecular analysis
    Zhao, Fu
    Zhang, Jing
    Li, Peng
    Zhou, Qiangyi
    Zhang, Shun
    Zhao, Chi
    Wang, Bo
    Yang, Zhijun
    Li, Chunde
    Liu, Pinan
    JOURNAL OF NEURO-ONCOLOGY, 2018, 139 (02) : 333 - 340
  • [46] Efficacy and safety of ruxolitinib cream for the treatment of vitiligo by patient demographics and baseline clinical characteristics: Pooled subgroup analysis from two randomized phase 3 studies
    Rosmarin, David
    Ezzedine, Khaled
    Desai, Seemal R.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB50 - AB50
  • [47] Comment on: A pooled subgroup analysis of glucarpidase treatment in 86 pediatric, adolescent, and young adult patients receiving high-dose methotrexate therapy in open-label trials
    Meyers, Paul A.
    PEDIATRIC BLOOD & CANCER, 2024, 70 (11)
  • [48] Benefits and costs of immunizing children against influenza at school: An economic analysis based on a large-cluster controlled clinical trial
    Schmier, Jordana
    Li, Su
    King, James C., Jr.
    Nichol, Kristin
    Mahadevia, Parthiv J.
    HEALTH AFFAIRS, 2008, 27 (02) : W96 - W104
  • [49] Clinical benefits of precision medicine in treating solid cancers: European Society of Medical Oncology-Magnitude of Clinical Benefit Scale score-based analysis
    Hibino, Y.
    Ito, M.
    Satake, T.
    Kondo, S.
    ESMO OPEN, 2021, 6 (04)
  • [50] Perampanel in adult epilepsy patients treated in everyday clinical practice: results from an interim pooled analysis of real-world studies
    Strzelczyk, Adam
    Wehner, Tim
    Deleo, Francesco
    Carreno, Mar
    Trinka, Eugen
    Wu, Tony
    Dash, Amitabh
    Villanueva, Vicente
    EPILEPSIA, 2021, 62 : 150 - 150
12345